The core targets enriched in the signaling pathway of NAFLD mainly include IL1B, MAPK8, AKT1, IL6, and TNF, etc., which further provides an important scientific basis for demonstrating the mechanism of andrographololides against NASH. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatotic liver disease.